Drug Trial Radar · NCT07930767
Phase I Trial of RBD4059 in Chinese Healthy Participants
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Aug 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Suzhou Ribo Life Science Co. Ltd.Industry
- Sponsor type
- Industry
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, sponsor-open, placebo-controlled, single-dose phase I study. The goal of this clinical trial is to evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and tolerability of RBD4059 in Chinese healthy participants. Participants will receive single doses of RBD4059 or placebo, and need about 16 visits for checkups and tests until End of trial.
Conditions
- Healthy
Interventions
RBD4059Drug
Subcutaneously Administered RBD4059 in Healthy Participants.
PlaceboDrug
Subcutaneously Administered Placebo in Healthy Participants.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Plasma concentrations of RBD4059Time frame: Until 48 hours after injection
- PharmacodynamicsTime frame: Until Day 169
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.